Our cloud-based AI framework and indication agnostic platform enable genomic professionals to easily manage the entire genetic sequencing process. This facilitates the creation of virtual plug-and-play genetic test modules that deliver clinically actionable insights and disease diagnoses.
Genoox Clinical Applications
Next generation sequencing is one of the most powerful tools for rare disease diagnosis. Genoox provides this diagnosis using singleton analysis, trio or family analysis using either whole-exome, whole genome or dedicated gene panels. Our solution automatically prioritizes potential causative genomic variants by confidently identifying and classifying pathogenic variants according to ACMG guidelines, and matching patient phenotypes with relevant and up-to-date clinical evidence.
Genoox platform enables the creation and validation of virtual panels and assays, based on whole-exome or whole genome sequencing data. This allows genetic institutes to rapidly and effectively expand their testing methods, while using a single workflow, and deliver more accurate, simpler diagnostics for phenotypic-driven analysis.
With the advances in research, the genetic cause for more and more diseases becomes known. Genoox delivers clinically actionable recommendations by identifying and reporting mutations for various hereditary diseases. We do this by providing dedicated, gene-specific workflows which are built on top of our community-powered knowledge base and our large database of known disease-associated genetic variations from single or heterogenetic backgrounds.
Genoox streamlines workflows for utilizing molecular data in a clinical setting, and enables use of complex genomic data in novel ways to refine oncology patient treatment strategies and improve outcomes
Genoox facilitates the identification of mutations associated with an increased risk for various cancers including breast, Ovarian, Colorectal and others. We provide a comprehensive set of assessment tools to classify and prioritize variants and streamline the process of generating clinically-actionable reports and predominant risk estimates based on observed alterations.
Genoox helps predict drug exposure-response relationships, granting genomic professionals a better understanding of each patient's unique genetic makeup. This helps genomic clinicians select therapies with fewer side effects, optimize drug dosing and assess personal disease risk.
Genoox simplifies laboratory processes, facilitating the use of high-precision preconception screening and family planning. We work with various vendors on a variety of gene panels and provide full solutions that cover the entire spectrum - from carrier screening through newborn genetic testing.
Created for professionals,
Genoox is the creator of the world’s first open genomic community. Our users leverage our vendor-neutral, workflow-agnostic platform to create accurate data insights across the genomic value chain.
The right tools to
empower your pipeline
Genoox is a wholly modular platform that enables selection of relevant tools to maximize the efficiency and accuracy of your NGS pipeline.
Our AI engine provides the best classifier based on any publicly available data source. It suggests relevant evidence, refines metrics and addresses gene-specific recommendations - delivering a fully-transparent ACMG\AMP-based variant classification.
Reach all available data,
use only what is relevant
Genoox prioritizes and aggregates frequently-updated information from published research, new and existing archives, and curated and uncurated databases. We filter out ‘noise’ and highlight evidence crucial to your decision making.
Genoox generates a durable genomic data repository that can be queried against variant statistics - maximizing linkage and assessment for comprehensive clinical classification and reporting using curated information and historical sample data.